A multidisciplinary team of Cornell researchers is collaborating to elevate the value of home care workers while improving their working conditions and patient outcomes.
Researchers analyzed the Omicron wave in Qatar last winter, comparing prior infections, vaccine immunity and combinations thereof among more than 100,000 Omicron-infected and non-infected individuals.
As the pandemic pomp and COVID circumstances dissipate, Cornell’s McGovern Center and Praxis Center incubators graduated five startups, putting them on the road to success.
A study suggests boosting “naturally-produced” antibodies in mothers may enhance infants’ immunity against bacterial pathogens that cause infectious gastrointestinal diseases.
The annual event showcased the wide range of cancer research taking place across Cornell colleges and campuses, and allowed faculty and students to identify potential areas for collaboration.
A class of proteins, known as TMEM16 scramblases, permit rearrangement of lipids in the cell membrane chiefly by thinning the membrane, according to a new model by Weill Cornell Medicine investigators.
As the cherished rainforest in South America’s Amazon River region continues to shrink, the river itself now presents evidence of other dangers: the overexploitation of freshwater fish.
Our 11th episode features Stephanie Wisner ’16, co-founder of Centivax, a therapeutics company that’s creating universal vaccines to reduce and eradicate the remaining complex pathogens of the 21st century.
Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia, according to a preclinical study by investigators at Weill Cornell Medicine.
